Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

SIMPLE SUMMARY: Patients with Triple Negative Breast Cancer (TNBC) have a poor prognosis due to high inter-tumor heterogeneity and absence of effective targeted treatments. Through quantification of ongoing processes in each individual with TNBC, we propose an explanation on why certain previously s...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasudevan, Swetha, Adejumobi, Ibukun A., Alkhatib, Heba, Roy Chowdhury, Sangita, Stefansky, Shira, Rubinstein, Ariel M., Kravchenko-Balasha, Nataly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507629/
https://www.ncbi.nlm.nih.gov/pubmed/34638492
http://dx.doi.org/10.3390/cancers13195009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507629/
https://www.ncbi.nlm.nih.gov/pubmed/34638492
http://dx.doi.org/10.3390/cancers13195009

Ejemplares similares